Cuando la respuesta es correcta, pero la pregunta no: el caso de la sífilis congénita

Smith P, Morrow R, Ross D. Types of intervention and their development. En Field Trials of Health Interventions, 3 ed. Oxford: Oxford Medicine Online; 2015. https://doi.org/10.1093/med/9780198732860.003.0002

Chou R, Aronson N, Atkins D, et al. Assessing harms when comparing medical interventions. En: Methods Guide for Effectiveness and Comparative Effectiveness Reviews [Internet]. Rockville: Agency for Healthcare Research and Quality; 2008. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK47098/

Levine M, Walter S, Lee H, Haines T, Holbrook A, Moyer V. Users' guides to the medical literature. IV. How to use an article about harm. Evidence-Based Medicine Working Group. JAMA. 1994;271(20):1615-9. https://doi.org/10.1001/jama.271.20.1615.

Fletcher R, Fletchert S, Wagner E. Treatment. En: Clinical Epidemiology. The Essentials, 3 ed. Baltimore: Williams & Wilkins; 1996.

Matar C, Kahale L, Hakoum M, Tsolakian I, Etxeandia-Ikobaltzeta I, Yosuico V, et al. Anticoagulation for perioperative thromboprophylaxis in people with cancer. Cochrane Database Syst Rev. 2018;7(7):CD009447. https://doi.org/10.1002/14651858.CD009447

Muñoz N, Kjaer S, Sigurdsson K, Iversen O, Hernandez-Avila M, Wheeler C, et al. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. J Natl Cancer Inst. 2010;102(5):325-39. https://doi.org/10.1093/jnci/djp534

Kleijnen J, Gøtzsche P, Kunz R, Oxman A, Chalmers I. So what’s so special about randomisation? En: Maynard A, Chalmers I, editors. Non-random reflections on health services research: On the 25th anniversary of Archie Cochrane’s Effectiveness and Efficiency. BMJ Books; 1997. p. 93-106.

Higgins J, Savović J, Page M, Elbers R, Sterne J. Assessing risk of bias in a randomized. En: Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al., editors [Internet]. Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane; 2024. Disponible en: https://www.cochrane.org/authors/handbooks-and-manuals/handbook

Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis. 1967;20(8):637-48. https://doi.org/10.1016/0021-9681(67)90041-0.

Gordis L. Ensayos clínicos con distribución aleatoria. Algunos aspectos adicionales. En Gordis L. Epidemiologia, 3 ed. Madrid: Elsevier; 2005.

Schmidt M, Parner E. The conclusion generator. Ann Epidemiol. 2024;97:33-7. https://doi.org/10.1016/j.annepidem.2024.06.008.

Richardson S, Hirsch J, Narasimhan M, Crawford J, McGinn T, Davidson K, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323(20):2052-9. https://doi.org/10.1001/jama.2020.6775

Rendón-Macías M, Riojas-Garza A, Contreras-Estrada D, Martínez-Ezquerro J. Análisis bayesiano. Conceptos básicos y prácticos para su interpretación y uso. Rev Alerg Mex. 2018;65(3):285-98. https://doi.org/10.29262/ram.v65i3.512.

Rücker G, Schwarzer G. Ranking treatments in frequentist network meta-analysis works without resampling methods. BMC Med Res Methodol. 2015;15:58. https://doi.org/10.1186/s12874-015-0060-8

Chaimani A, Higgins J, Mavridis D, Spyridonos P, Salanti G. Graphical tools for network meta-analysis in STATA. PLoS ONE. 2013;8(10):76654. https://doi.org/10.1371/journal.pone.0076654.

US Food & Drug Administration. Division of Biostatistics Office of Surveillance and Biometrics. Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials 2010 [Internet]. White Oak: FDA; 2010. Disponible en: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/guidance-use-bayesian-statistics-medical-device-clinical-trials

Lorach H, Galvez A, Spagnolo V, Martel F, Karakas S, et al. Walking naturally after spinal cord injury using a brain-spine interface. Nature. 2023;618(7963):126-33. https://doi.org/10.1038/s41586-023-06094-5.

Dekkers O, Egger M, Altman D, Vandenbroucke J. Distinguishing case series from cohort studies. Ann Intern Med. 2012;156(1 Pt 1):37-40. https://doi.org/10.7326/0003-4819-156-1-201201030-00006.

Glasziou P, Chalmers I, Rawlins M, McCulloch P. When are randomised trials unnecessary? Picking signal from noise. BMJ. 2007;334(7589):349-51. https://doi.org/10.1136/bmj.39070.527986.68.

Workowski K. The 1998 CDC Sexually Transmitted Diseases Treatment Guidelines. Curr Infect Dis Rep. 2000;2(1):44-50. https://doi.org/10.1007/s11908-000-0086-9.

Alexander J, Sheffield J, Sanchez P, Mayfield J, Wendel G Jr. Efficacy of treatment for syphilis in pregnancy. Obstet Gynecol. 1999;93(1):5-8. https://doi.org/10.1016/s0029-7844(98)00338-x.

Workowski K, Berman S. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep. 2006;55(RR-11):1-94.

Janier M, Unemo M, Dupin N, Tiplica G, Potočnik M, Patel R. 2020 European guideline on the management of syphilis. J Europ Acad Dermatol Venereol. 2021;35(3):574-88. https://doi.org/10.1111/jdv.16946

Ministerio de Salud y Protección Social. Fondo de Población de las Naciones Unidas (UNFPA). Guía de práctica clínica basada en la evidencia para la atención integral de la sífilis gestacional y congénita [Internet]. GPC; 2014. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/INEC/IETS/gpc-guia-completa-sifilis.pdf

Hunt A, Banner N, Littler K. The global forum on bioethics in research meeting, "ethics of research in pregnancy": Emerging consensus themes and outputs. Reprod Health. 2017;14(Suppl 3):158. https://doi.org/10.1186/s12978-017-0431-1.

Watson-Jones D, Changalucha J, Gumodoka B, Weiss H, Rusizoka M, Ndeki L, et al. Syphilis in pregnancy in Tanzania. I. Impact of maternal syphilis on outcome of pregnancy. J Infect Dis. 2002;186(7):940-7. https://doi.org/10.1086/342952.